About Spring Bioscience
Spring Bioscience is a company based in Pleasanton (United States) founded in 2001 was acquired by Ventana in September 2007. Spring Bioscience offers products and services including Primary Antibodies, ELISA Kits, and Cell Lines. Spring Bioscience operates in a competitive market with competitors including Abcam, Stem Cell Technologies, Meridian Bioscience, OriGene and Sangon Biotech, among others.
- Headquarter Pleasanton, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Abcam Limited
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Spring Bioscience
Spring Bioscience offers a comprehensive portfolio of products and services, including Primary Antibodies, ELISA Kits, and Cell Lines.
Tools for detecting specific proteins in biological samples.
Kits for quantitative analysis of proteins and antibodies.
Gene-edited lines to support advanced research experiments.
Funding Insights of Spring Bioscience
Detailed funding history for Spring Bioscience
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Spring Bioscience
Spring Bioscience has secured backing from 1 investor. Prominent investors backing the company include Ventana.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Ventana Medical Systems Inc, a member of the Roche Group, innovates and manufactures instruments and reagents that automate tissue processing and slide staining
|
Locked | Locked | Locked |
Investor details for Spring Bioscience
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Spring Bioscience
Investment portfolio details for Spring Bioscience
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Spring Bioscience
Detailed financials for Spring Bioscience
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Spring Bioscience Comparisons
Peer comparison for Spring Bioscience
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Spring Bioscience
Spring Bioscience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abcam, Stem Cell Technologies, Meridian Bioscience, OriGene and Sangon Biotech, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Biological reagents and antibodies are developed for life science research.
|
|
| Locked | Locked | Locked |
Developer of cell culture media and ancillary reagents for life science research
|
|
| Locked | Locked | Locked |
Molecular diagnostic device and kits
|
|
| Locked | Locked | Locked |
Proteins, antibodies, and molecular tools are manufactured for research applications.
|
|
| Locked | Locked | Locked |
Research services, reagents, and kits for biotech applications are provided.
|
|
| Locked | Locked | Locked |
Molecular biology reagents and kits are supplied for research applications.
|
Detailed competitors of Spring Bioscience
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Spring Bioscience
Complete news archive for Spring Bioscience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Spring Bioscience
Spring Bioscience was founded in 2001.
Spring Bioscience is headquartered in Pleasanton, United States. It is registered at Pleasanton, California, United States.
Spring Bioscience develops a variety of monoclonal antibodies for clinical immunohistochemistry applications. The company uses proprietary recombinant technology to develop SP Clone rabbit monoclonal antibodies. Its product line includes monoclonal antibodies, Detection ancillaries (Antibody diluent, citrate buffer, REVEAL Biotin-free detection system, Epitope RecoveryPretreatment, Detection component, Chromogen, BufferDiluentMiscellaneous, Blocking reagent, Biotin-Streptavidin detection system); and recombinant proteins. In 2007, the company got acquired by Ventana Medical Systems for its antibody development capabilities and shortly thereafter Ventana was acquired by Roche.
Spring Bioscience's top competitors include Abcam, Meridian Bioscience and Stem Cell Technologies.
Spring Bioscience offers Primary Antibodies, ELISA Kits, and Cell Lines.
Spring Bioscience has 1 investor. Key investors include Ventana.